Smoking may increase the usage of antidepressant: evidence from genomic perspective analysis

Richardson S, McNeill A, Brose LS (2019) Smoking and quitting behaviours by mental health conditions in Great Britain (1993–2014). Addict Behav 90:14–19

Article  PubMed  PubMed Central  Google Scholar 

Burki TK (2021) WHO releases latest report on the global tobacco epidemic. Lancet Oncol 22(9):1217

Article  PubMed  Google Scholar 

Mao Y, Zhang N, Liu J et al (2019) A systematic review of depression and anxiety in medical students in China. BMC Med Educ 19(1):1–13

Article  CAS  Google Scholar 

Shorey S, Ng ED, Wong CHJ (2022) Global prevalence of depression and elevated depressive symptoms among adolescents: a systematic review and meta-analysis. Br J Clin Psychol 61(2):287–305

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention (CDC) (2008) Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. MMWR Morb Mortal Wkly Rep 57(45):1226–1228

Google Scholar 

World Health Organization. Regional Office for Europe (2019) European tobacco use: trends report 2019. World Health Organization. Regional Office for Europe. https://apps.who.int/iris/handle/10665/346817

Lasser K, Boyd JW, Woolhandler S et al (2000) Smoking and mental illness: a population-based prevalence study. JAMA 284(20):2606–2610

Article  CAS  PubMed  Google Scholar 

Oliveira P, Ribeiro J, Donato H et al (2017) Smoking and antidepressants pharmacokinetics: a systematic review. Ann Gen Psychiatry 16:1–8

Article  CAS  Google Scholar 

Korhonen T, Loukola A, Wedenoja J et al (2014) Role of nicotine dependence in the association between the dopamine receptor gene DRD3 and major depressive disorder. PLoS One 9(6):e98199

Article  PubMed  PubMed Central  Google Scholar 

Broms U, Wedenoja J, Largeau MR et al (2012) Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits. Nicotine Tob Res 14(6):720–733

Article  CAS  PubMed  PubMed Central  Google Scholar 

Korhonen T, Koivumaa-Honkanen H, Varjonen J et al (2011) Cigarette smoking and dimensions of depressive symptoms: longitudinal analysis among Finnish male and female twins. Nicotine Tob Res 13(4):261–272

Article  CAS  PubMed  Google Scholar 

Hahad O, Beutel M, Gilan DA et al (2022) The association of smoking and smoking cessation with prevalent and incident symptoms of depression, anxiety, and sleep disturbance in the general population. J Affect Disord 313:100–109

Article  PubMed  Google Scholar 

Kagabo R, Gordon AJ, Okuyemi K (2020) Smoking cessation in inpatient psychiatry treatment facilities: a review. Addict Behav Rep 11:100255

PubMed  PubMed Central  Google Scholar 

Wills L, Ables JL, Braunscheidel KM et al (2022) Neurobiological mechanisms of nicotine reward and aversion. Pharmacol Rev 74(1):271–310

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arias HR, Targowska-Duda KM, García-Colunga J et al (2021) Is the antidepressant activity of selective serotonin reuptake inhibitors mediated by nicotinic acetylcholine receptors? Molecules 26(8):2149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Husky MM, Mazure CM, Paliwal P et al (2008) Gender differences in the comorbidity of smoking behavior and major depression. Drug Alcohol Depend 93(1–2):176–179

Article  PubMed  Google Scholar 

Spring B, Pingitore R, McChargue DE (2003) Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am J Psychiatry 160(2):316–322

Article  PubMed  Google Scholar 

Royal College of Psychiatrists (2013) Smoking and Mental Health. Royal College of Physicians, London

Google Scholar 

Korhonen T, Ranjit A, Tuulio-Henriksson A et al (2017) Smoking status as a predictor of antidepressant medication use. J Affect Disord 207:221–227

Article  PubMed  Google Scholar 

Chéron-Launay M, Le Faou AL, Sévilla-Dedieu C et al (2011) Smoking and the consumption of antidepressants, anxiolytics and hypnotic drugs: results of a large, French epidemiological study in 2005. Addict Behav 36(7):743–748

Article  PubMed  Google Scholar 

Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 375:n2233

Article  PubMed  PubMed Central  Google Scholar 

Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408

Article  PubMed  PubMed Central  Google Scholar 

Zhu H, Sun Y, Guo S et al (2023) Causal relationship between sex hormone-binding globulin and major depression: A Mendelian randomization study. Acta Psychiatr Scand 148(5):426–436

Article  CAS  PubMed  Google Scholar 

Zhu H, Lu R, Zhou Q et al (2023) Relationship between sphingomyelin and risk of Alzheimer’s disease: a bidirectional mendelian randomization study. J Alzheimer’s Dis Rep 7(1):1289–1297

Article  Google Scholar 

Du Z, Guo S, Sun Y et al (2023) Causal relationships between dietary habits and five major mental disorders: a two-sample Mendelian randomization study. J Affect Disord 340:607–615

Article  PubMed  Google Scholar 

Ji Y, Du Z, Zheng K et al (2023) Bidirectional causal association between ischemic stroke and five mental disorders. Acta Psychiatr Scand 148(4):359–367

Article  PubMed  Google Scholar 

Sekula P, Fabiola Del Greco M, Pattaro C et al (2016) Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol 27(11):3253

Article  PubMed  PubMed Central  Google Scholar 

Liu M, Jiang Y, Wedow R et al (2019) Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet 51(2):237–244

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowden J, Del Greco MF, Minelli C et al (2016) Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 45(6):1961–1974

PubMed  PubMed Central  Google Scholar 

Burgess S, Dudbridge F, Thompson SG (2016) Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 35(11):1880–1906

Article  PubMed  Google Scholar 

Bowden J, Del Greco MF, Minelli C et al (2017) A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36(11):1783–1802

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Haycock PC et al (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314

Article  PubMed  PubMed Central  Google Scholar 

Yuan S, Carter P, Mason AM et al (2022) Genetic liability to rheumatoid arthritis in relation to coronary artery disease and stroke risk. Arthritis Rheumatol 74(10):1638–1647

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nolte IM (2020) Metasubtract: an R-package to analytically produce leave-one-out meta-analysis GWAS summary statistics. Bioinformatics 36(16):4521–4522

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rognli EB, Bramness JG, von Soest T (2022) Smoking in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, antidepressants and anxiolytics. Psychol Med 52(14):3241–3250

Article  PubMed  Google Scholar 

Zhao M, Ma J, Li M et al (2021) Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci 22(23):12808

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bousman CA, Stevenson JM, Ramsey LB et al (2023) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther 114:51–68

Article  CAS  PubMed  Google Scholar 

Protti M, Mandrioli R, Marasca C et al (2020) New-generation, non-SSRI antidepressants: drug–drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Med Res Rev 40(5):1794–1832

Article  CAS  PubMed  Google Scholar 

Austin-Zimmerman I, Wronska M, Wang B et al (2021) The influence of CYP2D6 and CYP2C19 genetic variation on diabetes mellitus risk in people taking antidepressants and antipsychotics. Genes 12(11):1758

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiemke C, Bergemann N, Clement HW et al (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(01/02):9–62

Article 

留言 (0)

沒有登入
gif